Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CelVivo has developed a patented bioreactor system—ClinoStar and disposable Clinoreactors—that enables researchers to grow cells as spheroids or organoids under low shear stress conditions. This allows cells to retain or recover their physiological attributes more closely mimicking in vivo tissue compared to traditional flat cultures. The technology supports long-term cell culture and has been used in developmental biology, neuroscience, oncology, and liver disease modeling. It helps bridge the gap between animal testing and human-relevant data by providing more predictive in vitro systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CelVivo.